{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-009986","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.978898+00:00","generated_at":"2026-05-15T12:37:54.950821+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"bioAffinity 2025 revenue $6.2M; CyPath Lung revenue up 87% YoY, net loss $14.9M","bullets":["Total revenue $6.2M, down 34% from $9.4M in 2024 due to discontinuing unprofitable pathology services.","CyPath Lung revenue increased 87% YoY; tests performed up 99%, physician orders up 67%.","Net loss $14.9M vs $9.0M in 2024, driven by warrant fair value changes and higher commercialization costs.","Cash $6.5M at year-end; raised $16.9M in equity in 2025. Guidance: >100% CyPath Lung unit sales growth in 2026.","Appointed Gordon Downie MD PhD as CMO; Roberto Rios CPA and John Oppenheimer MD to board of directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-009986","json":"https://secwatch.observer/filing/0001493152-26-009986.json","markdown":"https://secwatch.observer/filing/0001493152-26-009986.md","text":"https://secwatch.observer/filing/0001493152-26-009986.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226009986/0001493152-26-009986-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226009986/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T12:37:54.950821+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}